Mirtoplus Tablet 40/12.5mg

Adult dose

For patients whose blood pressure is not adequately controlled by telmisartan alone, this medication should be taken once daily with water regardless of meals. Telmisartan/Hydrochlorothiazide combination in dosages of 40/12.5mg, 80/12.5mg, 80/25mg can be administered based on blood pressure control status. Before starting treatment, sodium or blood volume depletion should be addressed, and caution should be exercised for renal impairment, hepatic impairment, and the elderly.

Child dose

Safety and efficacy have not been established for children under 18 years of age.

This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Pregnant and breastfeeding women should not take this medication, and patients with hypersensitivity should avoid it. Administration is contraindicated in patients with severe liver or kidney impairment. Elderly patients or those with specific heart disease, liver disease, or kidney disease should use this medication with caution; care is needed if blood pressure becomes excessively low. This medication may increase the risk of skin cancer, so exposure to sunlight should be limited and skin conditions should be regularly monitored. Dizziness, hypotension, and electrolyte imbalances may occur during use, necessitating regular blood tests and monitoring of conditions. There are numerous interactions with other medications, requiring periodical checks of blood pressure, kidney function, and serum electrolyte levels. Caution is needed while driving or operating machinery as drowsiness or dizziness may occur. Overdose may lead to hypotension and electrolyte abnormalities, warranting immediate medical assistance. Safety and effectiveness have not been established for children, and its use is not recommended in this population. This medication is sensitive to moisture and should be taken out of the package just before use and stored out of reach of children.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, severe skin reactions, breathlessness or difficulty breathing, asthma attacks, respiratory anomalies accompanied by cough and fever, breathing problems, jaundice (yellowing of skin or eyes), extreme lethargy, liver abnormalities (jaundice), sudden

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, visual disturbances, blurred vision, lightheadedness, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, respiratory distress, pneumonitis, pulmonary edema, diarrhea, dry mouth, bloating, abdominal pain, constipation, dyspepsia, vomiting, liver function abnormalities/liver impairment, erythema, pruritus, rash, sweating, low back pain

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, preferably at a temperature between 1 and 30 degrees Celsius. Warm or excessively cold locations should be avoided, and it should be kept in a cool place away from direct sunlight.

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle